Large Banner Ad
Small Banner Ad

July 26, 2017

Chemotherapy causes cancer?

Scott Stockdale

More by this author...

Despite the continued use of chemotherapy as the mainstay to treat cancer patients, researchers recently increased their estimate of the number of Canadians who will die from cancer from two-in-five, to one-in-two.

Meanwhile, a 14-year study published in the Journal of Clinical Oncology in December 2004 called “The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies” (Clinical Oncology (2004) 16: 549e560 doi:10.1016/j.clon.2004.06.007) showed that the overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1 % in the United States.

Moreover, several doctors have stated on the record that chemotherapy actually causes more cancer to develop in patients.

According to Dr. John Diamond, M.D., “A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy.”

Moreover, Dr. Allen Levin and Dr. Glen Warner said chemotherapy actually kills the patients before the cancer does.

The late Dr. Glenn Warner (he died in 2000) – one of the most highly qualified cancer specialists in American - used alternative treatments on his cancer patients with great success. He said chemotherapy was killing people for profit.

“We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.”

Dr. Allen Levin concurred with Dr. Warner's conclusion that chemotherapy kills people.

“Most cancer patients in this country die of chemotherapy. Chemotherapy does not eliminate breast, colon, or lung cancers. This fact has been documented for over a decade, yet doctors still use chemotherapy for these tumors,” Dr. Levin said.

In his book, The Topic of Cancer: When the Killing Has to Stop, Dick Richards cites a number of autopsy studies which have shown that cancer patients actually died from conventional treatments before the tumor had a chance to kill them.

Dr. Petter Glidden, a member of the American Association of Naturopathic Physicians and the Illinois Association of Naturopathic Physicians, who received his BS degree from the University of Massachusetts in Amhurst and earned his ND from Bastyr University in Seattle, Washington, said chemotherapy is still used because doctors and pharmaceutical companies make money from it.

“That's the only reason: not because it's effective, decreases morbidity, mortality or diminishes any specific cancer rates. In fact, it does the opposite. Chemotherapy boosts cancer growth and long-term mortality rates. Most chemotherapy patients either die or are plagued with illness within 10-15 years after treatment. It destroys their immune system, increases neuro-cognitive decline, disrupts endocrine functioning and causes organ and metabolic toxicities. Patients basically live in a permanent state of disease until their death.”

Moreover,  he added that “The cancer industry” (pharmaceutical companies and doctors) marginalizes safe and effective cures while promoting their patented, expensive, and toxic remedies, whose risks far exceed any benefit.

“This is what they do best, and they do it because it makes money, plain and simple.”

Dr. Glidden said toxic chemotherapy drugs just happen to take a little longer to kill than many  other poisonous substances – such as cyanide and arsenic -  and he said they're designed that way for a good reason.

“We couldn't have people dropping like flies one week after receiving chemo or the gig would be over. Again, that would be bad for business.”

With these kind of claims, one has to wonder how researchers manage to promulgate a “one-in-two” chance of survival for those who take conventional cancer treatments, which means chemotherapy and radiation.

Dr. Glidden said it's  clear to any trained eye that initial lesions that are doubtful, or debatable, as to whether or not they are malignant, represent the overwhelming majority of the tumours being detected. In other words, patients with these lesions are either unlikely, or much less likely to develop malignant cancer than those who definitely cancer tumours. By including these initial lesions, which Dr. Glidden characterizes as “presumed neoplasias”, researchers are able to inflate survival rates for chemotherapy patients.

“It is equally clear how often these presumed neoplasias (tumours), which are often subject to both misunderstanding and manipulation, inflate those statistics to the point of implausibility.”

He added that the reason a five-year relative survival rate is the standard used to assess mortality rates is due to most cancer patients going downhill after this period.

Meanwhile, Dr. Glidden said if the long-term statistics (ten plus years) for all cancers administered chemotherapy produced the objective data on rigorous evaluations, including the cost-effectiveness, impact on the immune system, quality of life, morbidity and mortality, it would be very clear that chemotherapy makes little to no contribution to cancer survival at all. But he intimated that this is not going to happen any time soon because researchers are funded by corporations - mainly pharmaceutical companies - which make a fortune from chemotherapy drugs.

“No such study has ever been conducted by independent investigators in the history of chemotherapy. The only studies available come from (cancer) industry funded institutions and scientists and none of them have ever inclusively quantified the above variables.”

He added that clinical studies never inclusively assess the long-term survival and recovery rates of cancer patients because damage to the immune system, organ and metabolic toxicities, endocrine challenges and neurocognitive problems slowly develops after chemotherapy.

“It often does not begin to manifest throughout the body until several months or even years have passed. It takes time, but within a 3-5 year period, most chemotherapy patients begin to have many more symptoms of disease than they ever had before their diagnosis, due to and as a direct result of cytotoxic drug intervention.”

This may be, in no small part, because chemotherapy does not target cancer cells and it kills far more normal cells than cancer cells and damages and toxifies many of the normal cells that do survive.

  • Think green before you print
  • Respond to the editor
  • Email
  • Delicious
  • Twitter
  • Facebook
  • MySpace
  • StumbleUpon
Subscribe to the E-bulletin

FULL SPEECH: Trudeau addresses UN General Assembly

Subscribe to our YouTube Channel